| Identification | |
| Name: | Cefotaxime sodium |
| CAS: | 64485-93-4 |
| EINECS: | 264-915-9 |
| Molecular Formula: | C16H16N5NaO7S2 |
| Molecular Weight: | 477.44731 |
| InChI: | InChI=1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9-;/t10-,14-;/m0./s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.8 g/cm3 |
| Stability: | Stable. Incompatible with strong oxidizing agents. |
| Appearance: | White to pale yellow crystalline powder |
| Specification: |
?Cefotaxime sodium , its cas register number is 64485-93-4. It also can be called Claforan ; CTX ; and [6R-[6alpha,7beta(z)]]-3-[(Acetyloxy)methyl]-[[(2-amine-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid monosodium salt . |
| HS Code: | 29419000 |
| Color: | white to yellow |
| Usage: | Broad spectrum third generation cephalosporin antibiotic. The name Cefotaxime applies to the isomer having a syn-methoxy imino group |
| Safety Data | |
| Hazard Symbols |
Xn: Harmful
|
 |
|
